BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $394,000 | -20.9% | 7,800 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $498,000 | +86.5% | 7,800 | +200.5% | 0.01% | +71.4% |
| Q3 2021 | $267,000 | +1.9% | 2,596 | -12.7% | 0.01% | -12.5% |
| Q2 2021 | $262,000 | +12.4% | 2,975 | +24.1% | 0.01% | -11.1% |
| Q1 2021 | $233,000 | -87.7% | 2,398 | -90.1% | 0.01% | -93.1% |
| Q2 2020 | $1,894,000 | +310.0% | 24,283 | +395.6% | 0.13% | +209.5% |
| Q2 2019 | $462,000 | -5.5% | 4,900 | -19.7% | 0.04% | -10.6% |
| Q1 2019 | $489,000 | +22.6% | 6,104 | -17.5% | 0.05% | -19.0% |
| Q4 2018 | $399,000 | -12.3% | 7,401 | +27.1% | 0.06% | +28.9% |
| Q3 2018 | $455,000 | -74.8% | 5,823 | -87.1% | 0.04% | -86.6% |
| Q1 2017 | $1,808,000 | – | 45,200 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |